IFNG and neoplasm: Of note, the MHC class II antigen, which is known to be subject to regulation by IFN-γ, was significantly upregulated in the tumor following HCA587 protein vaccine treatment (data not shown), which may render the tumor more vulnerable to CD4+ T cells attack.